🇺🇸 FDA
Pipeline program

Taneasy 600mg granules

BCQ230209TP

Approved small_molecule completed

Quick answer

Taneasy 600mg granules for COPD (Chronic Obstructive Pulmonary Disease) is a Approved program (small_molecule) at Biotech Pharmaceutical Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Biotech Pharmaceutical Co.,
Indication
COPD (Chronic Obstructive Pulmonary Disease)
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials